Shire on hold by Jefferies

Shire Pharmaceuticals Group plc was rated at hold by Jefferies & Co., Inc. analyst Robin Campbell after strong fourth-quarter Adderall XR and Fosrenol sales pushed full-year 2005 product sales to a record high. Shares of the Chineham, England, pharmaceutical company were up 15.50p, or 1.74%, at 906.50p on volume of 3,565,873 shares versus the three-month running average of 4,084,720 shares. (London: SHP)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.